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• Primary percutaneous coronary 
intervention (PPCI) is the gold standard of 
treatment of ST segment elevation 
myocardial infarction (STEMI). 
•  PPCI restores thrombolysis in myocardial 
infarction flow 3 (TIMI 3) in over 90% of 
patients [1].  
• However, in rare instances, coronary 
revascularization does not lead to 
coronary reperfusion, instead there is a 
further decrease of coronary blood flow.  
• The cause of no-reflow can be classified 
into four main pathogenetic components: 
distal athero-thrombotic embolization, 
ischemia-related and/or reperfusion-
related injury, and the susceptibility of 
coronary microcirculation to injury.  
• The purpose of this case report is to show 
early and clear identification of the no re-
flow and follow its management. It can 
occur in up to 10% of cases of primary PCI 
and is associated with an increased 30 
day mortality if not adequately treated 
(32% vs. 2.8%, p<.0. 001) [2]. 
 
 
INTRODUCTION 
• A 76-yr-old female presented to the 
emergency department with new-onset 
substernal chest pain over 3 days. 
•  Her primary care physician initially 
diagnosed her with GERD, but then her 
chest pain acutely worsened and she 
developed dyspnea on exertion as well 
• PMH: hypertension, hyperlipidemia, type 
2 diabetes mellitus, Raynaud’s disease, 
rheumatoid arthritis, degenerative joint 
disease, and Sjogren’s disease.  
• Vital Signs: blood pressure 52/44 ,  pulse 
of 122, respiratory rate of 20, 
temperature 36.8 C, and SpO2 100% on 
room air.  
• Physical Exam: findings were 
unremarkable. 
• EKG: On admission showed an 
anterolateral wall ST-elevation myocardial 
infarction (STEMI) for which she had to be 
taken emergently for left heart 
catheterization.  
• Hospital Course:  During PCI, she had a 
drug-eluting stent (DES) placed to 100% 
lesion of the proximal LAD but there was 
no re-flow following placement.  
• The patient became bradycardic, 
hypotensive, and agonal; within a few 
minutes she had two episodes of cardiac 
arrest with return of spontaneous 
circulation (ROSC) achieved with CPR, 
epinephrine, and atropine.  
• She then had to be sedated and 
intubated, started on a norepinephrine 
bitartrate drip for hypotension.  
• For her no re-flow after stenting and 
coronary vasospasm, she was treated 
with intracardiac nicardipine, adenosine, 
and eptifibatide.  
• There was subsequent placement of IABP  
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which was upgraded to a right femoral artery 
Impella®. Unfortunately, there was  
subsequent development of Impella® site 
bleeding and a right groin hematoma. 
• On Day 2 of hospitalization, the patient’s 
MAP dropped below 65 with increasing 
pressor requirements. CBC showed Hb 5.5 
following 8 units of pRBC, which was 
concerning for acute blood loss, and 
patient’s right groin hematoma was 
expanding to the abdominal wall and 
down her right thigh. 
• At this point, the patient was urgently 
transferred to University of Pennsylvania 
for further evaluation. 
 
 
 
 
 
 
 
 
 
• The prognosis and presentation of patients 
with coronary no re-flow can vary.  
• For the last few decades, treatment of no 
re-flow has been mostly 
pharmacotherapy-based, without much 
success. There is a poor prognostic effect 
of no-reflow causing an increase in five-
year mortality from 9.5 to 18.2 percent  
• This case depicts why it is important to 
recognize coronary no re-flow early and to 
continue exploring treatment options. 
1South Jersey Heart Group, Lourdes Cardiology Services, NJ , 2 Rowan University SOM, Division of Cardiology, NJ,  
3Rowan University SOM, Department of Medicine,  NJ 
 
DISCUSSION 
• For our patient, PCI did not lead to the 
usual and expected restoration of 
coronary blood flow.   
• She had evidence of angiographic 
no-reflow phenomenon characterized by 
evidence of slow-flow in the affected vessel 
(TIMI flow equal to or less than 2) and lack 
of contrast uptake “blush” by the 
subtended myocardium, leading to a 
potential dissociation between coronary 
revascularization and myocardial perfusion 
in STEMI [3]. ”  
• There are several treatment options for 
no re-flow, although it is not known 
which treatment is best 
• Current medical treatment options are 
the following: injection of adenosine 
(dilator of arteries and arterioles), 
nitroprusside sodium (relaxes arteries 
and veins), and verapamil (smooth 
muscle dilator) [2, 3].  
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• Figure 1:  Acute 100% 
occlusion of LAD 
• Figure 2:  Drug eluting stent 
placed  
• Figure 3:  Intracoronary 
infusion of nicardipine, 
adenosine, and eptifibatide, 
with minimal improvement.  
TIMI Score 1-2 
